Publications by authors named "M Mourtalla Ka"

[Not Available].

Ann Cardiol Angeiol (Paris)

March 2025

Dilated cardiomyopathy is a rare and often little-known complication of pheochromocytoma, it is likewise exceptionally its discovery circumstance. This is usually an acute, reversible cardiomyopathy.We report the case of a 20-year-old young adult hospitalized for hypokinetic dilated cardiomyopathy with severe impairment of left ventricular ejection fraction (LVEF) to 17%.

View Article and Find Full Text PDF

Cyclin E1 (CCNE1) amplification is associated with poor prognosis of ovarian carcinomas across histological subtypes. Inhibitors targeting PLK1 or WEE1 are emerging as promising therapeutic agents for cancer treatment that disrupt the critical G2/M checkpoint, leading to cancer cell death. However, biomarkers that predict the response to these inhibitors are not well defined.

View Article and Find Full Text PDF

The aim of this study was to evaluate the subclinical patterns and evolution of cardiac abnormalities via transthoracic echocardiography (TTE) in patients with mild initial COVID-19 illness. A total of 343 infected individuals (163 males; age 44 (interquartile range, IQR 35-52) years) years) underwent serial TTE assessments at a median of 109 (interquartile range (IQR), 77-177) and 327 (276-379) days after infection. Compared with those of non-COVID-19-infected controls (n = 94, male n = 49), baseline systolic (LVEF, TAPSE) and diastolic function (e', a', E/e') were significantly different in infected participants (p < 0.

View Article and Find Full Text PDF

This proposed scientific statement is focused on providing new insights regarding challenges and opportunities for cardiovascular health (CVH) promotion in Africa. The statement includes an overview of the current state of CVH in Africa, with a particular interest in the cardiometabolic risk factors and their evaluation through metrics. The statement also explains the main principles of primordial prevention, its relevance in reducing noncommunicable disease and the different strategies that have been effective worldwide.

View Article and Find Full Text PDF
Article Synopsis
  • Integrins are crucial receptors that help cells stick to their surroundings, and abnormal levels of integrins can lead to cancer progression and spread.
  • Integrin alpha-5 (ITGA5), which binds to proteins like fibronectin, was found to be linked with poor survival rates in patients with non-small cell lung cancer (NSCLC).
  • Experiments showed that increasing ITGA5 led to larger, more mobile cancer cells, while reducing ITGA5 returned those cells to normal behavior, suggesting that targeting ITGA5 could be a potential treatment strategy for NSCLC.
View Article and Find Full Text PDF